Publications by authors named "Michael Drazer"

Claim this Profile
G
Genomics of Acute Myeloid Leukemia at Diagnosis and Remission.
Kai Yu, Laura W Dillon, Jesse M Tettero, Gege Gui, Rasha W Al-Ali, Michael W Drazer

medRxiv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Video Education in Germline Genetic Testing: A Step Toward Improved Access to Personalized Medicine.
Sulin Wu, Cara Essling, Feighanne Hathaway, Michael William Drazer

JCO Oncol Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Pleural Mesothelioma: ASCO Guideline Clinical Insights.
Hedy L Kindler, Ibiayi Dagogo-Jack, Marc de Perrot, Michael W Drazer, Nofisat Ismaila

JCO Oncol Pract· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with relapsed/refractory acute leukaemia treated with revumenib with a focus on post-revumenib therapies.
Miles Thomas, Hannah Johnston, Emily Dworkin, Austin Wesevich, Gregory W Roloff, Michael W Drazer

Br J Haematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma.
Jennifer H Cooperrider, Diren Arda Karaoglu, Tadeusz Kubicki, Can Rui Jiang, Ella Postich, Michael W Drazer

Leukemia· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zeaxanthin augments CD8 effector T cell function and immunotherapy efficacy.
Freya Q Zhang, Jiacheng Li, Rukang Zhang, Jiayi Tu, Zhicheng Xie, Michael W Drazer

Cell Rep Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults.
Ethan J Harris, Diren Arda Karaoglu, Madina Sukhanova, Yasmin Abaza, Theodoros Karantanos, Michael W Drazer

Blood Cancer J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ANKRD26-related thrombocytopenia 2 with a baseline increase in blasts: implications for clinical surveillance.
Lara Wahlster, Lucy A Godley, Jason X Cheng, Michael W Drazer, Christopher R Reilly

Blood· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants.
Ryan J Stubbins, Stephen Arnovitz, Jennie Vagher, Anase Asom, Melody Perpich, Michael W Drazer

Leukemia· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for Patients With Myeloid Neoplasms Treated With Chemotherapy Plus Venetoclax After Prior Venetoclax Therapy.
Rafael Madero-Marroquin, Joseph Cannova, Emily Dworkin, Austin Wesevich, Gregory W Roloff, Michael W Drazer

EJHaem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germ line JAK2 variants and hereditary blood cancers.
Joseph Cannova, Michael W Drazer

Blood Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Pleural Mesothelioma: ASCO Guideline Update.
Hedy L Kindler, Nofisat Ismaila, Lyudmila Bazhenova, Quincy Chu, Jane E Churpek, Michael W Drazer

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation.
Gregory W Roloff, Satyajit Kosuri, Mariam T Nawas, Adam S DuVall, Anand A Patel, Michael W Drazer

Haematologica· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition.
Jiarna R Zerella, Claire C Homan, Peer Arts, Xuzhu Lin, Sam J Spinelli, Michael W Drazer

Blood· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FLT3 Agonists and Secondary Hematopoietic Malignancies: A Potential Class Effect.
Henry W Raeder, Michael W Drazer

Clin Cancer Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy.
Rafael Madero-Marroquin, Emily Dworkin, Howard Weiner, Caner Saygin, Mariam T Nawas, Michael W Drazer

Leuk Lymphoma· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: Venous Thromboembolism in Peritoneal Mesothelioma.
Varun V Bansal, Owen Mitchell, Michael W Drazer, Hedy L Kindler, Kiran K Turaga

Ann Surg Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms.
Amandeep Kaur, Alexandra E Rojek, Emily Symes, Mariam T Nawas, Anand A Patel, Michael W Drazer

Blood Cancer J· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous Thromboembolism in Peritoneal Mesothelioma: Uncovering the Hidden Risk.
Varun V Bansal, Owen Mitchell, Celyn Bregio, Hunter D D Witmer, Ankit Dhiman, Michael W Drazer

Ann Surg Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CML and the WHO: Why?
Ellin Berman, Neil P Shah, Michael Deninger, Jessica K Altman, Maria Amaya, Michael Drazer

J Clin Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Neil P Shah, Ravi Bhatia, Jessica K Altman, Maria Amaya, Kebede H Begna, Michael Drazer

J Natl Compr Canc Netw· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adults.
Hannah Johnston, Hamed Rahmani Youshanlouei, Clinton Osei, Anand A Patel, Adam DuVall, Michael Drazer

Blood Adv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.
Claire C Homan, Michael W Drazer, Kai Yu, David M Lawrence, Jinghua Feng

Blood Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical guideline variability in the diagnosis of hereditary hematopoietic malignancy syndromes.
Adam Hamidi, Gregory W Roloff, Reid Shaw, Maria Acevedo, Shaili Smith, Michael W Drazer

Leuk Lymphoma· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma.
Owen D Mitchell, Katie Gilliam, Daniela Del Gaudio, Kelsey E McNeely, Shaili Smith, Michael W Drazer

JAMA Netw Open· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis